Riskpilot← Back to searchSign inGet full accessBioShare AB
ABActiveOrg 5591098024Steffens Väg 431Manufacture of other special-purpose machinery n.e.c. · NACE 2899Est. 20176 employees
Revenue 2024
SEK 9M
+11% vs 2023
EBITDA margin
-3.5%
+79% vs 2023
Equity ratio
72.7%
Financial strength
Net profit 2024
SEK -984K
+45% vs 2023
| Revenue | SEK 9M | +11% |
| EBITDA | SEK -315K | +79% |
| Net profit | SEK -984K | +45% |
| Total assets | SEK 7,4M | -58% |
| Equity | SEK 5,4M | -15% |
| Employees | 6 | — |
Legal name
BioShare AB
Org number
5591098024
Legal form
Aktiebolag
NACE code
2899 · Manufacture of other special-purpose machinery n.e.c.
Founded
24 april 2017
Share capital
SEK 105 067
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva teknik- och projektutveckling inom området bränslen och kemikalier samt därmed förenlig verksamhet.
Address
Steffens Väg 431
Email
christer.gustavsson@bioshare.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | 417 | 794 | 1 219 | 218 | 425 | 8 159 | 9 037 |
| Staff expenses | — | — | — | — | — | −3 856 | −3 784 | −4 296 |
| EBITDA | −15 | −253 | −1 020 | −2 432 | −3 677 | −1 346 | −1 485 | −315 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | — | −453 | −680 |
| EBIT | −15 | −253 | −1 020 | −2 432 | −3 677 | −1 346 | −1 938 | −995 |
| Net financials | — | — | — | — | −1 | 24 | 137 | 60 |
| Profit before tax | −15 | −253 | −1 020 | −2 433 | −3 678 | −1 322 | −1 801 | −984 |
| Tax | −0 | −0 | −0 | −0 | −0 | — | — | — |
| Net profit | −15 | −253 | −1 020 | −2 433 | −3 678 | −1 322 | −1 801 | −984 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 91 | 2 668 | 2 816 | 3 499 | 15 586 | 13 710 | 17 508 | 7 423 |
| Equity | 35 | 1 282 | 2 262 | 130 | 9 501 | 8 179 | 6 379 | 5 395 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | — | — | — |
| Short-term debt | 56 | 1 386 | 554 | 3 369 | 6 084 | 5 531 | 11 129 | 2 028 |
| Total debt | 56 | 1 386 | 554 | 3 369 | 6 084 | 5 531 | 11 129 | 2 028 |
EBITDA margin
-3.5%
This company
15.8%
Market median
-122% vs market
20172024
Equity ratio
72.7%
This company
38.2%
Market median
+90% vs market
20172024
Return on equity
-18.2%
This company
18.4%
Market median
-199% vs market
20172024
Net profit margin
-10.9%
This company
8.1%
Market median
-235% vs market
20172024
Asset turnover
1.22×
This company
1.12×
Market median
+9% vs market
20172024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20172024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-04-01 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JF Chief Auditor | Chief Auditor | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Deputy Board Member | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BioShare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Fredrik Axel Eklund | Chief Auditor | 0 companies |
| Lars Lennart Stigsson | Board of Directors | 0 companies |
| Hans Christer Gustavsson | Chairman | 0 companies |
| Sten Helmer Holmberg | Board of Directors | 0 companies |
| Carl Christian Stigsson | Board of Directors | 0 companies |
| Helena Madeleine Gustavsson | Deputy Board Member | 0 companies |